| Literature DB >> 33176721 |
Maria Glans1,2, Annika Kragh Ekstam3, Ulf Jakobsson4, Åsa Bondesson4,5, Patrik Midlöv4.
Abstract
BACKGROUND: The area of hospital readmission in older adults within 30 days of discharge is extensively researched but few studies look at the whole process. In this study we investigated risk factors related, not only to patient characteristics prior to and events during initial hospitalisation, but also to the processes of discharge, transition of care and follow-up. We aimed to identify patients at most risk of being readmitted as well as processes in greatest need of improvement, the goal being to find tools to help reduce early readmissions in this population.Entities:
Keywords: Aged; Aged 80 and over; Patient readmission; Patient transfer; Polypharmacy; Potentially inappropriate medication list
Year: 2020 PMID: 33176721 PMCID: PMC7659222 DOI: 10.1186/s12877-020-01867-3
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Fig. 1The chain of events covered in the data collection includes patient characteristics prior to and events during the initial hospital stay as well as factors concerning the processes of discharge, transition of care and follow-up
Patient characteristics prior to admission
| Characteristic | Comparison group ( | Readmitted | |
|---|---|---|---|
| Agea, Mean (SD) | 78 (8) | 80 (8) | 0.072b |
| Female, % | 52 | 49 | 0.333c |
| Number of hospitalisations 12 months, Mean (SD) | 1.4 (1.0) | 2.0 (1.3) | |
| Number of visits to ER 6 months, Mean (SD) | 0.3 (0.7) | 0.5 (0.9) | |
| Charlson Comorbidity Index, Mean (SD) | 6 (3) | 8 (3) | |
| Nursing home, % | 11 | 13 | 0.299c |
| Own home, with spouse/other, % | 53 | 43 | |
| Own home, alone, % | 36 | 44 | |
| Own home with home care, % | 16 | 33 | |
| Help with activities in daily life, % | 12 | 19 | |
| Own home with home healthcare, % | 10 | 19 | |
| Help with medication from nurse, % | 16 | 25 | |
| Multi-dose drug dispensing, % | 14 | 22 | |
| Using walking aid, % | 44 | 60 | |
| Using wheelchair, % | 8.4 | 16 | |
Abbreviations: ER Emergency Room, SD Standard Deviation
aVariables included in the Charlson Comorbidity Index bStudents t-test cχ2-test dInternal missing 0.3–0.4% eInternal missing 3.1% fInternal missing 8.9%
Significant p-values are indicated in bold.
Active and previous comorbidities as stated in the hospital medical records
| Diagnosis | Comparison group ( | Readmitted | |
|---|---|---|---|
| Chronic ischaemic heart disease, % | 24 | 34 | |
| Myocardial infarctiona, % | 22 | 24 | 0.535b, d |
| Congestive heart failurea, % | 26 | 33 | |
| Peripheral vascular diseasea, % | 7.8 | 9.2 | 0.503b |
| CVAa or TIAa, % | 29 | 27 | 0.507b |
| Dementiaa, % | 13 | 17 | 0.141b, d |
| Chronic obstructive pulmonary diseasea, % | 13 | 26 | |
| Connective tissue diseasea, % | 22 | 20 | 0.463b |
| Peptic ulcer diseasea, % | 16 | 23 | |
| Mild liver diseasea, % | 0.6 | 2.2 | 0.063c, e |
| Severe liver diseasea, % | 0.0 | 1.1 | 0.124c |
| Diabetes mellitusa, % | 17 | 21 | 0.130b |
| Hemiplegiaa, % | 2.5 | 1.9 | 0.613c |
| Kidney failure stadium IVa, % | 4.5 | 14 | |
| History of cancer, % | 31 | 44 | |
| Solid tumoura, % | 14 | 26 | |
| Metastatic tumoura, % | 3.9 | 14 | |
| Leukaemiaa, % | 1.9 | 1.9 | 1.000c |
| Lymphomaa, % | 0.8 | 3.3 | |
| AIDSa, % | – | – | – |
| Leg ulcer, % | 3.3 | 7.5 | |
| Atrial fibrillation, % | 28 | 37 | |
| History of embolic disease, % | 8.3 | 14 |
Abbreviations: CVA Cerebrovascular accident, TIA Transient ischaemic attack, SD Standard Deviation
aVariables included in the Charlson Comorbidity Index bχ2-test cFishers’ exact test dInternal missing 0.1–0.3% eInternal missing 0.7–1.1%
Significant p-values are indicated in bold.
Variables related to the initial hospitalisation and discharge
| Variable | Comparison group ( | Readmitted | |
|---|---|---|---|
| Emergent hospitalisation, % | 88 | 93 | 0.058c |
| Hospitalisation related to cancer diagnosis, % | 6.9 | 11 | 0.051c |
| Length of stay, Mean (SD) | 6.9 (7.2) | 7.8 (5.2) | 0.063b |
| Length of stay 5 days or longer, % | 53 | 66 | |
| Plasma sodium level, mmol/L, Mean (SD) | 140 (3.7) | 139 (3.8) | 0.267b, e |
| Plasma potassium level, mmol/L, Mean (SD) | 4.0 (0.4) | 4.0 (0.4) | 0.815b, e |
| Blood haemoglobin level, g/L, Mean (SD) | 124 (19.2) | 119 (18.1) | |
| Relative eGFRa, Mean (SD) | 59 (18.2) | 55 (20.9) | |
| Body Mass Index < 22, kg/m2, % | 30 | 35 | 0.153c, f |
| Minor surgery/diagnostic procedure, % | 33 | 37 | 0.241c |
| Major surgery, % | 31 | 21 | |
| Discharged Monday-Thursday, % | 70 | 66 | 0.230c, d |
| Discharged Friday or day before holiday, % | 19 | 27 | |
| Discharged weekend or holiday, % | 11 | 6.7 | 0.064c, d |
| Discharged from Internal medicine, % | 56 | 54 | 0.600c |
| Discharged from General surgery, % | 21 | 28 | |
| Discharged from Infection, % | 7.2 | 6.1 | 0.550c |
| Discharged from Orthopaedics, % | 11 | 8.9 | 0.320c |
| Discharged from Gynaecology/ENT unit, % | 4.2 | 3.3 | 0.556c |
Abbreviations: ENT Ear Nose Throat, eGFR Estimated Glomerular Filtration Rate, SD Standard Deviation
aVariables included in the Charlson Comorbidity Index bStudent’s t-test cχ2-test dInternal missing 0.4–1.7% eInternal missing 3.2–4.6% fInternal missing 13.5%
Significant p-values are indicated in bold.
Medications, medication review and transfer of medication information at discharge
| Variable | Comparison group ( | Readmitted | |
|---|---|---|---|
| Number of medications in total, Mean (SD) | 9.0 (4.9) | 11 (5.3) | |
| Number of daily medications, Mean (SD) | 7.2 (3.8) | 8.8 (4.1) | |
| Number of medications as needed, Mean (SD) | 1.8 (1.8) | 2.4 (2.1) | |
| Polypharmacya, % | 74 | 86 | |
| Excessive polypharmacyb, % | 24 | 42 | |
| Diuretics, % | 41 | 52 | |
| Antihypertensive medications (not diuretics), % | 68 | 72 | 0.256e |
| Anticoagulants (including LMWH), % | 27 | 34 | |
| Anti-platelet drugs, % | 39 | 32 | 0.052e |
| Insulin, % | 9.7 | 14 | 0.066e |
| Digoxin, % | 4.2 | 4.2 | 1.000e |
| Opiates, % | 31 | 37 | 0.098e |
| No of PIMs, Mean (SD) | 0.17 (0.41) | 0.16 (0.44) | 0.662d |
| No of FRIDs, Mean (SD) | 3.24 (2.24) | 3.64 (2.13) | |
| Use of three or more psychoactive drugs, % | 10.0 | 9.2 | 0.704d |
| Changes in medications made during stay, % | 84 | 88 | 0.110e |
| New medications started, % | 79 | 75 | 0.249e |
| Medications withdrawn, % | 23 | 31 | |
| Dosages adjusted, % | 24 | 34 | |
| Medication changes in discharge summary, % | 58 | 51 | 0.061e, f |
| Medication changes in medical case history, % | 52 | 47 | 0.180e |
| Medication report correct, % | 56 | 50 | 0.124e |
Abbreviations: LMWH Low Molecular Weight Heparin, PIM Potentially Inappropriate Medication, FRID Fall Risk Increasing Drug, SD Standard Deviation
aDefined as the daily use of five medications or more bDefined as the daily use of 10 medications or more cAccording to the Swedish National Board of Health and Welfare dStudents t-testeχ2-test fInternal missing 0.1%
Significant p-values are indicated in bold.
Variables associated with readmission to hospital within 30 days of dischargea
| Variable | OR | 95% CI | |
|---|---|---|---|
| Gender | 0.89 | 0.63–1.25 | 0.500 |
| Emergent admission | 1.43 | 0.73–2.77 | 0.297 |
| Charlson Comorbidity Index | 1.12 | 1.04–1.20 | |
| Number of hospitalisations 12 months | 1.41 | 1.19–1.68 | |
| Length of stay 5 days or longer | 1.72 | 1.18–2.49 | |
| Day of discharge (reference: Monday-Thursday) | |||
| Friday/Day before weekend/holiday | 1.88 | 1.24–2.87 | |
| Weekend/Holiday | 0.83 | 0.44–1.54 | 0.551 |
| Discharging unit (reference: Internal medicine) | |||
| General surgery | 2.09 | 1.34–3.24 | |
| Infection | 0.54 | 0.26–1.13 | 0.101 |
| Orthopaedics | 1.02 | 0.53–1.96 | 0.949 |
| Gynaecology/Ear Nose Throat | 1.47 | 0.55–3.93 | 0.442 |
| Living in own home with home care | 1.61 | 1.06–2.45 | |
| Major surgery performed during Index | 0.59 | 0.37–0.94 | |
| Excessive polypharmacyb | 1.66 | 1.15–2.40 |
Abbreviations: CI Confidence Interval
aAdjusted for gender, type of admission and age (within the age-adjusted Charlson Comorbidity Index) bDefined as the daily use of 10 medications or more
Hosmer Lemeshow goodness of fit test p-value: 0.457. Nagelkerke R2: 0.228.
Significant p-values are indicated in bold.